Gennadi
Egutkin
Biography
Education and degrees completed
December 2008: Docent tenure (Adjunct Professor) at the Faculty of Medicine, University of Turku (UTU) in the area of “Enzyme immunology” (Diploma #746/141/2008)
October 1989: Candidate of Biological Sciences (equivalent to PhD) in Biochemistry & Endocrinology. Institute of Endocrinology and Metabolism, Kiev, Ukraine
1984 – 1987: Postgraduate Student. Institute of Radiobiology, Academy of Sciences of Belarus, Minsk, Belarus
1979 – 1984: Master of Science. Faculty of Biology, Department of Biochemistry, Belarus State University, Minsk, Belarus (finished with excellence)
Current employment and previous work experience
1998 – present: Senior Scientist, Docent, MediCity Research Laboratory, UTU, Finland.
1997 – 1998: Senior Research Fellow, Royal Free Hospital, University College London, England.
1987 – 1997: Scientific Researcher, Institute of Radiobiology, Academy of Sciences of Belarus, Minsk, Republic of Belarus.
Teaching
Principal supervisor (PS) or co-supervisor (co-S) for: Bachelor’s thesis of Camilla Tallgren (Turku University of Applied Sciences; May 2011, PS) • Master of Science (MSc) thesis of Mikko Helenius (UTU; March 2011, PS) • PhD thesis of Mariachiara Zuccarini (University of Chieti-Pescara, Italy; April 2015, PS) • PhD thesis of Mikko Helenius (University of Helsinki; October 2015, co-S) • MSc thesis of Marius Paul (University of Bonn [UB], Germany; May 2019, PS) • MSc thesis of Nora Kreisig (UB, September 2024, PS) • MSc thesis of Samuel Svärd (UTU; November 2024, PS) • PhD thesis of Karolina Losenkova (UTU; March 2025, PS) • MSc thesis of Julia Baier (UB, April 2026, PS)• MSc thesis of Ursula von Danwitz (UB, PS). Currently, I am supervising PhD Theses of Samuel Svärd (UTU, PS) and Shaghayegh Hasanpour (UTU, co-S).
The following visiting researchers, undergraduate and PhD students received training in MediCity under my supervision: Dr. Nathalie Mercier (Nancy, France; 2008–2010) • Anne Meyer (UB, April–June 2014) • Justyna Kowal (University of Copenhagen, Denmark, December 2014) • Mariachiara Zuccarini (University of Chieti-Pescara, Italy, September 2014 – February 2015) • Valeria Quarona (University of Torino, Italy, April 2015) • Octavia Cadassou (University of Lyon, France, January – February 2017) • Karolina Losenkova (Moscow Institute of Physics, Russia, October 2015 – November 2017) • Julian Zeiner (UB, May – October 2017) • Marius Paul (UB, January – May 2018) • Corinna Weiler (UB, May – October 2021) • Nora Kreisig (UB, May – October 2023) • Joanna Pomeroy (University of Portsmouth, UK, July 2024) • Ursula Johanna von Danwitz (UB, May – October 2025) • Julia Baier (UB, July 2025 – February 2026) • Johanna Beining (UB, June – November 2026).
Lecturing activity: oral presentations and invited lectures (selected from the last 5 years)
- University of Iceland, Reykjavik, Iceland (June 2022).
- 3rd International Meeting of Purinergic Signaling, Buzios, Brazil (September 2022).
- 1st eCOST PRESTO meeting, Ferrara, Italy (February 2023)
- University of Portsmouth, Portsmouth, The United Kingdom (April 2023).
- 2nd eCOST PRESTO meeting, Pisa, Italy (September 2023)
- 2nd Adenosine-Pathway Cancer Immunotherapy Summit, Boston, USA (June 2023)
- Duke University School of Medicine, Durham, USA (June 2023).
- University Medical Center Hamburg-Eppendorf, Hamburg, Germany (November 2023).
- University of Coimbra, Coimbra, Portugal (March 2024)
- University of Bonn, Bonn, Germany (July 2024)
- 2nd European Purine Meeting, Ferrara, Italy (September 2024)
- 4th eCOST PRESTO meeting, Dublin, Ireland (May 2025)
- 5th eCOST PRESTO meeting, Portsmouth, The United Kingdom (February 2026)
- 3rd European Purine Meeting, Bordeaux, France (July 2026)
Along with a primary focus on supervising research and student training, I gave an annual course of topical lectures to student of the Medical Faculty (UTU, Finland) in 2008-2022.
Research
My research focus for the past 25 years has been to investigate cellular metabolism in various pathophysiological states. I have especially contributed to the papers dealing with role of purine-converting enzymes in cancer, inflammation and vascular remodelling. Overall, I have >100 publications including six Invited Review Articles and four Book Chapters. These papers have been cited 6100 times (h-index 43; Web of Science™).
2010 – 2018: My Review (Yegutkin, Biochim Biophys Acta, 2008) was ranked as a “highly cited paper” in the top 1% in the field of Molecular Biology & Genetics (984 citations, Web of Science™) • 2025: Our Review (Yegutkin & Boison, Pharm Rev, 2022) was ranked as a “hot paper” in the top 0.1% in the field of Pharmacology & Toxicology (148 citations).